Magnesium dysregulation and risk of inflammatory skin disease: A multicenter cohort study

Authors

  • Natalia Chalupczak Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL, USA Author
  • Alexa S. Podolsky Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA Author
  • Shari R. Lipner Department of Dermatology, Weill Cornell Medicine, New York, NY, USA Author

DOI:

https://doi.org/10.25251/nnzpm9sp

Keywords:

acne, atopic dermatitis, magnesium, psoriasis, TriNetX

Abstract

Background: Magnesium is essential for epidermal differentiation and immune regulation, and dysregulated magnesium homeostasis has been implicated in chronic inflammation. However, its association with inflammatory skin diseases has been poorly characterized.

Objective: To investigate whether abnormal serum magnesium levels are associated with increased risk of psoriasis, atopic dermatitis, and acne in a real world population.

Methods: Using the TriNetX multicenter database, adults aged 18-65 years with hypomagnesemia (serum magnesium 0.0-1.6 mg/dL) or hypermagnesemia (≥2.6 mg/dL) were identified on November 12, 2025 (query range 2008-2025) and propensity score matched 1:1 to controls with normal magnesium levels. Matching variables included age, sex, race, ethnicity, chronic kidney disease (stages 1-5), bariatric surgery, and alcohol related disorders. Risk ratios (RR) and odds ratios with 95% confidence intervals (CIs) were calculated using logistic regression. Significance was set at p<0.05.

Results: After matching, 246,648 patients with hypomagnesemia and 86,649 patients with hypermagnesemia, as well as respective controls were included. Hypomagnesemia was associated with significantly increased risk of psoriasis (RR 1.173; 95% CI 1.098-1.253; p<0.0001) and atopic dermatitis (RR 1.091; 95% CI 1.027-1.160; p=0.0051), but not acne (RR 0.971; 95% CI 0.931- 1.014; p=0.1843). Hypermagnesemia was not significantly associated with psoriasis, atopic dermatitis, or acne (all p≥0.05). 

Conclusion: Hypomagnesemia, but not hypermagnesemia, was associated with increased risk of psoriasis and atopic dermatitis. These findings suggest a potential role for magnesium deficiency in cutaneous inflammatory pathogenesis and warrant further mechanistic and longitudinal studies.

References

1. Chalupczak NV, Lipner SR. The role of magnesium in dermatology. JAAD Rev. Published online October 2025. doi:10.1016/j.jdrv.2025.10.004

2. Qi L, Yang X. Association between magnesium depletion score and prevalence and all-cause mortality of psoriasis among the US population. Front Nutr. 2025;12:1598688.

3. Toyran M, Kaymak M, Vezir E, et al. Trace element levels in children with atopic dermatitis. J Investig Allergol Clin Immunol. 2012;22(5):341-344.

4. Lipkin G, March C, Gowdey J. Magnesium in epidermis, dermis, and whole skin of normal and atopic subjects. J Invest Dermatol. 1964;42(4):293-304.

5. Proksch E, Nissen HP, Bremgartner M, Urquhart C. Bathing in a magnesium-rich Dead Sea salt solution improves skin barrier function, enhances skin hydration, and reduces inflammation in atopic dry skin. Int J Dermatol. 2005;44(2):151-157.

6. Veronese N, Pizzol D, Smith L, Dominguez LJ, Barbagallo M. Effect of magnesium supplementation on inflammatory parameters: A meta-analysis of randomized controlled trials. Nutrients. 2022;14(3):679.

Downloads

Published

07/06/2026

Data Availability Statement

The data used in this study were obtained from the TriNetX research network, which provides access to de-identified patient-level information under a data use agreement. Due to licensing and privacy restrictions, these data cannot be publicly shared. Researchers may request access to the TriNetX platform directly through TriNetX subject to institutional approval and data use agreements.